Novel oncogene and tumor suppressor mutations inKITandPDGFRAwild type gastrointestinal stromal tumors revealed by next generation sequencing
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel oncogene and tumor suppressor mutations inKITandPDGFRAwild type gastrointestinal stromal tumors revealed by next generation sequencing
Authors
Keywords
-
Journal
GENES CHROMOSOMES & CANCER
Volume 54, Issue 3, Pages 177-184
Publisher
Wiley
Online
2014-11-27
DOI
10.1002/gcc.22230
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BRAF Mutant Gastrointestinal Stromal Tumor: First report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance
- (2015) Gerald S. Falchook et al. Oncotarget
- Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition
- (2015) Eleftherios P. Samartzis et al. Oncotarget
- Recurrent SMARCA4 mutations in small cell carcinoma of the ovary
- (2014) Petar Jelinic et al. NATURE GENETICS
- Dedifferentiation in Gastrointestinal Stromal Tumor to an Anaplastic KIT-negative Phenotype
- (2013) Cristina R. Antonescu et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Novel Clinically Relevant Genes in Gastrointestinal Stromal Tumors Identified by Exome Sequencing
- (2013) S. F. Schoppmann et al. CLINICAL CANCER RESEARCH
- No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases
- (2013) Jerzy Lasota et al. MODERN PATHOLOGY
- Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling
- (2013) Gunther Zimmermann et al. NATURE
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- Coordinate Direct Input of Both KRAS and IGF1 Receptor to Activation of PI3 kinase in KRAS -Mutant Lung Cancer
- (2013) Miriam Molina-Arcas et al. Cancer Discovery
- KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors
- (2012) C. Miranda et al. CLINICAL CANCER RESEARCH
- Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers
- (2012) S. Dogan et al. CLINICAL CANCER RESEARCH
- Succinate Dehydrogenase Subunit B (SDHB) Is Expressed in Neurofibromatosis 1-Associated Gastrointestinal Stromal Tumors (Gists): Implications for the SDHB Expression Based Classification of Gists
- (2012) Jeanny H. Wang et al. Journal of Cancer
- Detection of KRAS and BRAF Mutations in Colorectal Carcinoma
- (2011) Maria Arcila et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Coexistence of PIK3CA and Other Oncogene Mutations in Lung Adenocarcinoma-Rationale for Comprehensive Mutation Profiling
- (2011) J. E. Chaft et al. MOLECULAR CANCER THERAPEUTICS
- Integrative genomics viewer
- (2011) James T Robinson et al. NATURE BIOTECHNOLOGY
- Fast and accurate long-read alignment with Burrows–Wheeler transform
- (2010) Heng Li et al. BIOINFORMATICS
- Cell Cycle/Apoptosis Molecule Expression Correlates with Imatinib Response in Patients with Advanced Gastrointestinal Stromal Tumors
- (2009) S. Romeo et al. CLINICAL CANCER RESEARCH
- Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients
- (2008) C. Braconi et al. ANNALS OF ONCOLOGY
- Cigarette smoking and colorectal cancer incidence and mortality: Systematic review and meta-analysis
- (2008) Peter S. Liang et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More